Magnetic stimulation for treating spastic cerebral palsy
Lateral Cord Magnetic Stimulation For Refractory Spastic Cerebral Palsy - Multicenter Double Blind Randomized and Controlled Trial
This study is testing if magnetic stimulation can help improve movement and speech in people with spastic cerebral palsy who haven't found relief with other treatments.
Quick facts
| Phase | Phase2; Phase3 |
|---|---|
| Study type | Interventional |
| Enrollment | 20 (estimated) |
| Ages | 16 Years to 50 Years |
| Sex | All |
| Sponsor | Sociedad Argenttina de Neuromodulación Academic / other |
| Locations | 1 site (Hurlingham, Buenos Aires) |
| Trial ID | NCT03676439 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the use of lateral cord magnetic stimulation to improve motor function and speech in patients with refractory spastic cerebral palsy. The approach is based on previous findings that suggest this non-invasive technique can reduce abnormal muscle tone and enhance motor responses. Participants will undergo magnetic spinal stimulation to assess its efficacy in alleviating symptoms associated with spasticity. The study aims to provide a new therapeutic option for patients who have not responded to conventional treatments.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 16 years or older with stable spastic cerebral palsy, unilateral motor disability, and clinically evident speech disorders.
Not a fit: Patients with severe cardiac or respiratory disorders, psychiatric conditions, or other significant health issues may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could significantly improve the quality of life for patients with spastic cerebral palsy by enhancing motor function and speech capabilities.
How similar studies have performed: While the specific approach of lateral cord magnetic stimulation is novel, similar neuromodulation techniques have shown promise in other studies for treating spasticity and motor disorders.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 16 years or older. * Spastic Cerebral Palsy with stable condition. * Motor disability unilateral or predominantly unilateral. * Clinically evident speech disorders. * Normal or slightly subnormal intellectual coefficient (I.Q 80 or more) * Absence of psychiatric disorders Exclusion Criteria: * Cardiac or severe respiratory disorders. * Steady abnormal postures (except possible orthopedic surgical correction) * Recurrent chronic bronchial or pulmonary infections. * Psychiatric disorders * Chronic recurrent urinary infections * Severe osteoporosis in affected limbs * Chronic skin ulcers * Drug addiction. * Episodes of Status Epileptucus * Personal history, or in close relatives, of medical legal complaint
Where this trial is running
Hurlingham, Buenos Aires
- Centro de Rehabilitación San Juan de Dios — Hurlingham, Buenos Aires, Argentina (Recruiting)
Study contacts
- Principal investigator: Werner Braunsdorf, MD — Klinik von Magdeburg - Germany
- Study coordinator: Juan Carlos M Andreani, MD
- Email: jcmandreani@gmail.com
- Phone: 0111550531392
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.